"10.1371_journal.pone.0077448","plos one","2013-10-16T00:00:00Z","Felix DeAnda; Kendra E Hightower; Robert T Nolte; Kazunari Hattori; Tomokazu Yoshinaga; Takashi Kawasuji; Mark R Underwood","Chemical Sciences, GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America; Biological Sciences, GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America; Discovery Chemistry, Shionogi & Co., Ltd., Osaka, Japan; Infectious Diseases, Shionogi & Co., Ltd., Osaka, Japan; Chemistry Infectious Diseases, Shionogi & Co., Ltd., Osaka, Japan; Medicines Development Infectious Diseases, GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America","Conceived and designed the experiments: FD KH MU. Performed the experiments: FD KH. Analyzed the data: FD KEH RTN KH TY TK MU. Contributed reagents/materials/analysis tools: KEH RTN TY TK MU. Wrote the manuscript: FD KEH RTN KH TY TK MU.","Felix DeAnda, Kendra Hightower, Robert Nolte, and Mark Underwood are employees of GlaxoSmithKline, and Kazunari Hattori, Tomokazu Yoshinaga, and Takashi Kawasuji are employees of Shionogi & Co., Ltd. In addition, funding for this work was provided by ViiV Healthcare. The above does not alter the authors' adherence to all of the PLOS ONE policies on sharing data and materials.","2013","10","Felix DeAnda","FDA",7,TRUE,3,2,7,7,TRUE,TRUE,FALSE,0,NA,FALSE
